Similar articles for PMID: 33419834

Year	Number of Results
1996	1
1999	1
2001	1
2002	1
2003	1
2005	2
2006	3
2007	5
2008	5
2009	1
2010	3
2011	4
2012	5
2013	7
2014	3
2015	11
2016	5
2017	7
2018	4
2019	6
2020	5
2021	1
2024	0

1

A New Survival Score for Patients Receiving Radiotherapy for Newly Diagnosed Glioblastoma Multiforme.

Rades D, Witteler J, Schild SE, Trillenberg P, Bonsanto MM, Leppert J. Rades D, et al. Anticancer Res. 2021 Jan;41(1):379-384. doi: 10.21873/anticanres.14786. Anticancer Res. 2021. PMID: 33419834

2

Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years.

Ohno M, Miyakita Y, Takahashi M, Igaki H, Matsushita Y, Ichimura K, Narita Y. Ohno M, et al. Radiat Oncol. 2019 Nov 12;14(1):200. doi: 10.1186/s13014-019-1389-7. Radiat Oncol. 2019. PMID: 31718669 Free PMC article.

3

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff RO, Weller M, Cairncross JG, Eisenhauer E, Belanger K, Brandes AA, Allgeier A, Lacombe D, Stupp R. Gorlia T, et al. Lancet Oncol. 2008 Jan;9(1):29-38. doi: 10.1016/S1470-2045(07)70384-4. Epub 2007 Dec 21. Lancet Oncol. 2008. PMID: 18082451 Clinical Trial.

4

A pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival.

Abhinav K, Aquilina K, Gbejuade H, La M, Hopkins K, Iyer V. Abhinav K, et al. Clin Neurol Neurosurg. 2013 Aug;115(8):1375-8. doi: 10.1016/j.clineuro.2012.12.023. Epub 2013 Jan 18. Clin Neurol Neurosurg. 2013. PMID: 23333005

5

Prognostic Factors of Local Control and Survival in Patients Irradiated for Glioblastoma Multiforme (GBM).

Witteler J, Schild SE, Rades D. Witteler J, et al. Anticancer Res. 2020 Dec;40(12):7025-7030. doi: 10.21873/anticanres.14728. Epub 2020 Dec 7. Anticancer Res. 2020. PMID: 33288598

6

Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.

Lipani JD, Jackson PS, Soltys SG, Sato K, Adler JR. Lipani JD, et al. Technol Cancer Res Treat. 2008 Jun;7(3):249-55. doi: 10.1177/153303460800700311. Technol Cancer Res Treat. 2008. PMID: 18473497 Free article.

7

Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.

Ishikawa E, Muragaki Y, Yamamoto T, Maruyama T, Tsuboi K, Ikuta S, Hashimoto K, Uemae Y, Ishihara T, Matsuda M, Matsutani M, Karasawa K, Nakazato Y, Abe T, Ohno T, Matsumura A. Ishikawa E, et al. J Neurosurg. 2014 Sep;121(3):543-53. doi: 10.3171/2014.5.JNS132392. Epub 2014 Jul 4. J Neurosurg. 2014. PMID: 24995786 Clinical Trial.

8

Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).

Vordermark D, Ruprecht K, Rieckmann P, Roggendorf W, Vince GH, Warmuth-Metz M, Kölbl O, Flentje M. Vordermark D, et al. BMC Cancer. 2006 Oct 18;6:247. doi: 10.1186/1471-2407-6-247. BMC Cancer. 2006. PMID: 17049083 Free PMC article.

9

Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.

Kim BS, Seol HJ, Nam DH, Park CK, Kim IH, Kim TM, Kim JH, Cho YH, Yoon SM, Chang JH, Kang SG, Kim EH, Suh CO, Jung TY, Lee KH, Kim CY, Kim IA, Hong CK, Yoo H, Kim JH, Kang SH, Kang MK, Kim EY, Kim SH, Chung DS, Hwang SC, Song JH, Cho SJ, Lee SI, Lee YS, Ahn KJ, Kim SH, Lim DH, Gwak HS, Lee SH, Hong YK. Kim BS, et al. Cancer Res Treat. 2017 Jan;49(1):193-203. doi: 10.4143/crt.2015.473. Epub 2016 Jun 27. Cancer Res Treat. 2017. PMID: 27384161 Free PMC article.

10

Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.

Saito T, Sugiyama K, Takeshima Y, Amatya VJ, Yamasaki F, Takayasu T, Nosaka R, Muragaki Y, Kawamata T, Kurisu K. Saito T, et al. J Neurosurg. 2018 Mar;128(3):679-684. doi: 10.3171/2016.11.JNS162326. Epub 2017 Apr 21. J Neurosurg. 2018. PMID: 28430038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

73 results

Results by year